Showing results (2531-2540 of 6,794) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|March 5, 2004
Effects of glimepiride on insulin secretion and sensitivity in patients with recently diagnosed type 2 diabetes mellitusMary U Kabadi, Udaya M KabadiClinical Therapeutics|March 5, 2004
A claims analysis comparing citalopram with sertraline as initial pharmacotherapy for a new episode of depression: impact on depression-related treatment chargesTrent P McLaughlin, Michael T Eaddy, Amy N GrudzinskiClinical Therapeutics|March 25, 2004
Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational studyCarmen Turbí, Gabriel Herrero-Beaumont, Juan Carlos Acebes, et al.Clinical Therapeutics|March 25, 2004
A systematic review and meta-analysis of the efficacy and safety of a fixed, low-dose perindopril-indapamide combination as first-line treatment of hypertensionSheng Kang, Yang Feng Wu, Ning An, et al.Clinical Therapeutics|March 25, 2004
Health care cost of analgesic use in hypertensive patientsC Daniel Mullins, Fadia T Shaya, Louis R Flowers, et al.Clinical Therapeutics|March 25, 2004
A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disordersLinda Simoni-Wastila, Dennis Ross-Degnan, Connie Mah, et al.Clinical Therapeutics|January 11, 2005
Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapyDavid S H BellClinical Therapeutics|January 11, 2005
Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled studyHugues Malonne, Monte Coffiner, Bernard Sonet, et al.Clinical Therapeutics|January 11, 2005
Results of a randomized, double-blind, placebo-controlled study administering glimepiride to patients with type 2 diabetes mellitus inadequately controlled with rosiglitazone monotherapyDennis McCluskey, M Scott Touger, Robert Melis, et al.Clinical Therapeutics|January 11, 2005
Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipientsDirk R J Kuypers, Yves VanrenterghemPageof 680